168 related articles for article (PubMed ID: 36977496)
41. The Systemic Immune-Inflammation Index (SII) and coronary artery lesions in Kawasaki disease.
Huang T; Peng Q; Zhang Y; Zhu Z; Fan X
Clin Exp Med; 2024 Jan; 24(1):4. PubMed ID: 38231301
[TBL] [Abstract][Full Text] [Related]
42. High Serum Total IgE at Admission Is Associated with Coronary Artery Lesions in Children with Kawasaki Disease.
Wang Z; Liu X; Duan Z; Peng Y
J Trop Pediatr; 2022 Jan; 68(1):. PubMed ID: 35043965
[TBL] [Abstract][Full Text] [Related]
43. Serum Lp-PLA2 Level Predicting Coronary Artery Lesions in Children with Kawasaki Disease.
Zhang X; Ya-Wang Shao ; Ya-Lan Zhang ; Yi Liu
Heart Surg Forum; 2021 Jul; 24(4):E611-E618. PubMed ID: 34473042
[TBL] [Abstract][Full Text] [Related]
44. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
[TBL] [Abstract][Full Text] [Related]
45. Is There a Role for Laboratory Parameters in Predicting Coronary Artery Involvement in Kawasaki Disease?
Yalcinkaya R; Öz FN; Durmuş SY; Fettah A; Kaman A; Teke TA; Örün UA; Tanır G
Klin Padiatr; 2022 Nov; 234(6):382-387. PubMed ID: 35785802
[TBL] [Abstract][Full Text] [Related]
46. [Prediction of the risk of coronary arterial lesions in Kawasaki disease by N-terminal pro-brain natriuretic peptide].
Huiling L; Yaping L; Xiufen H
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):300-3. PubMed ID: 26182507
[TBL] [Abstract][Full Text] [Related]
47. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
Zhu F; Huang J; Wang X; Li P; Yan Y; Zheng Y; He Y; Wu T; Ren Y; Wu R
Chin J Physiol; 2020; 63(2):90-94. PubMed ID: 32341235
[TBL] [Abstract][Full Text] [Related]
48. Increased levels of circulating fibroblast growth factor 21 in children with Kawasaki disease.
Peng Y; Pei Q; Feng S; Su Y; Liu R; Yi Q; Guo P
Clin Exp Med; 2019 Nov; 19(4):457-462. PubMed ID: 31478099
[TBL] [Abstract][Full Text] [Related]
49. Myocardial work is independent risk factor for coronary artery lesions in children with Kawasaki disease.
Tang G; Zheng X; Liu K; Yu F; Zhang J
Coron Artery Dis; 2024 Mar; 35(2):149-155. PubMed ID: 38088792
[TBL] [Abstract][Full Text] [Related]
50. Clinical relevance of the risk factors for coronary artery lesions in Kawasaki disease.
Weng KP; Hsieh KS; Huang SH; Ou SF; Ma CY; Ho TY; Lai CR; Ger LP
Kaohsiung J Med Sci; 2012 Jan; 28(1):23-9. PubMed ID: 22226058
[TBL] [Abstract][Full Text] [Related]
51. Expression of PCT, BNP and Inflammatory Factors in Children with Kawasaki Disease and Their Correlation with Coronary Artery Lesions.
Feng H; Chai H; Li D; Shi C; Xu Y; Liu Y
Altern Ther Health Med; 2024 Jan; 30(1):302-306. PubMed ID: 37820655
[TBL] [Abstract][Full Text] [Related]
52. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
[TBL] [Abstract][Full Text] [Related]
53. Kawasaki Disease With Coronary Artery Lesions Detected at Initial Echocardiography.
Ae R; Maddox RA; Abrams JY; Schonberger LB; Nakamura Y; Kuwabara M; Makino N; Kosami K; Matsubara Y; Matsubara D; Sasahara T; Belay ED
J Am Heart Assoc; 2021 Apr; 10(7):e019853. PubMed ID: 33787310
[TBL] [Abstract][Full Text] [Related]
54. C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease.
Tsai CM; Yu HR; Tang KS; Huang YH; Kuo HC
Front Pediatr; 2020; 8():607631. PubMed ID: 33324592
[No Abstract] [Full Text] [Related]
55. The Relationship between Retinol-Binding Protein 4 and Markers of Inflammation and Thrombogenesis in Children with Kawasaki Disease.
Yang M; Weng H; Pei Q; Jing F; Yi Q
Mediators Inflamm; 2021; 2021():7029514. PubMed ID: 33505217
[TBL] [Abstract][Full Text] [Related]
56. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
Lu Y; Chen T; Wen Y; Si F; Wu X; Yang Y
BMC Pediatr; 2021 Sep; 21(1):406. PubMed ID: 34530763
[TBL] [Abstract][Full Text] [Related]
57. Tricuspid regurgitation in acute phase of Kawasaki disease associated with intensive care unit admission.
Lin YJ; Lin IC; Yu HR; Kuo HC; Yang KD; Chang WC; Liang CD; Liu SF; Kuo HC
Pediatr Cardiol; 2013 Feb; 34(2):250-5. PubMed ID: 22810044
[TBL] [Abstract][Full Text] [Related]
58. Red blood cell distribution width and tumor necrosis factor-α for the early prediction of coronary artery lesion in Kawasaki disease: a retrospective study.
Li J; Li DE; Hu M; Huang H; Xu S; Li H
Eur J Pediatr; 2022 Mar; 181(3):903-909. PubMed ID: 34494160
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
Liu J; Ye B; Su D; Qin S; Zhao W; Pang Y
Clin Rheumatol; 2023 Jan; 42(1):167-177. PubMed ID: 36129563
[TBL] [Abstract][Full Text] [Related]
60. Development of coronary artery lesions in indolent Kawasaki disease following initial spontaneous defervescence: a retrospective cohort study.
Takahashi T; Sakakibara H; Morikawa Y; Miura M
Pediatr Rheumatol Online J; 2015 Nov; 13(1):44. PubMed ID: 26530040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
